OptimizeRx Corp Annual Return On Equity in % from 2012 to 2023

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
OptimizeRx Corp quarterly/annual Return On Equity history and growth rate from 2012 to 2023.
  • OptimizeRx Corp Return On Equity for the quarter ending June 30, 2024 was -14.7 %, a 27.2% decline year-over-year.
  • OptimizeRx Corp annual Return On Equity for 2023 was -14.6 %, a 67.9% decline from 2022.
  • OptimizeRx Corp annual Return On Equity for 2022 was -8.67 %, a 2994% decline from 2021.
  • OptimizeRx Corp annual Return On Equity for 2021 was 0.3 %.
Return On Equity, Annual (%)
Return On Equity, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 -14.6 -5.89 -67.9% Jan 1, 2023 Dec 31, 2023
2022 -8.67 -8.97 -2994% Jan 1, 2022 Dec 31, 2022
2021 0.3 +5.1 Jan 1, 2021 Dec 31, 2021
2020 -4.8 +3.73 +43.7% Jan 1, 2020 Dec 31, 2020
2019 -8.53 -10.1 -649% Jan 1, 2019 Dec 31, 2019
2018 1.55 +34.2 Jan 1, 2018 Dec 31, 2018
2017 -32.6 -13.7 -72.5% Jan 1, 2017 Dec 31, 2017
2016 -18.9 -10.2 -118% Jan 1, 2016 Dec 31, 2016
2015 -8.67 +13.1 +60.2% Jan 1, 2015 Dec 31, 2015
2014 -21.8 -6.29 -40.6% Jan 1, 2014 Dec 31, 2014
2013 -15.5 +17.4 +52.9% Jan 1, 2013 Dec 31, 2013
2012 -32.8 Jan 1, 2012 Dec 31, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.